| scholarly article | Q13442814 |
| P50 | author | Yehuda Shoenfeld | Q1515807 |
| Udi Nussinovitch | Q90968171 | ||
| P2860 | cites work | New therapeutic strategies for systemic sclerosis--a critical analysis of the literature | Q24649115 |
| Ankle brachial pressure index (ABPI): An update for practitioners | Q24652795 | ||
| Large vessel occlusive disease associated with CREST syndrome and scleroderma | Q33565537 | ||
| Increased prevalence of symptomatic macrovascular disease in systemic sclerosis | Q33578449 | ||
| Diastolic abnormalities in systemic sclerosis: evidence for associated defective cardiac functional reserve | Q33579068 | ||
| Distribution of macrovascular disease in scleroderma | Q35548113 | ||
| Macrovascular disease and systemic sclerosis | Q35548842 | ||
| Detection of early impairment of coronary flow reserve in patients with systemic sclerosis | Q35553128 | ||
| Evaluation of the effect of nifedipine upon myocardial perfusion and contractility using cardiac magnetic resonance imaging and tissue Doppler echocardiography in systemic sclerosis | Q35555996 | ||
| Vascular injury in systemic sclerosis: angiotensin-converting enzyme insertion/deletion polymorphism | Q35689010 | ||
| Intravenous immunoglobulins improve the function and ameliorate joint involvement in systemic sclerosis: a pilot study | Q35954432 | ||
| Oxidized LDL/beta2-glycoprotein I complexes: new aspects in atherosclerosis | Q36283486 | ||
| Accelerated atherosclerosis in autoimmune rheumatic diseases | Q36318870 | ||
| Early atherosclerosis in systemic sclerosis and its relation to disease or traditional risk factors | Q36757042 | ||
| Macrovascular disease and atherosclerosis in SSc. | Q37102816 | ||
| Macrovascular disease in systemic sclerosis: the tip of an iceberg? | Q37265796 | ||
| Atherosclerosis in autoimmune rheumatic diseases-mechanisms and clinical findings | Q37319989 | ||
| Autoimmunity and heart diseases: pathogenesis and diagnostic criteria | Q37427500 | ||
| Cardiac complications of systemic sclerosis | Q37504315 | ||
| Erectile dysfunction in systemic sclerosis | Q37518933 | ||
| Anti-lipoprotein lipase antibody in systemic sclerosis: association with elevated serum triglyceride concentrations | Q81597280 | ||
| Assessment of arterial medial characteristics in human carotid arteries using integrated backscatter ultrasound and its histological implications | Q81637698 | ||
| Serum levels of heat shock protein 70, a biomarker of cellular stress, are elevated in patients with systemic sclerosis: association with fibrosis and vascular damage | Q81980668 | ||
| Angiographically proven coronary artery disease in scleroderma | Q83136221 | ||
| The penile vasculature in systemic sclerosis: A duplex ultrasound study | Q83302323 | ||
| Infections and autoimmunity--friends or foes? | Q37567077 | ||
| Catheter angiography and angioplasty in patients with scleroderma | Q39589913 | ||
| Systemic sclerosis is not associated with clinical or ambulatory blood pressure | Q39649394 | ||
| Improvement of vascular endothelial function using the oral endothelin receptor antagonist bosentan in patients with systemic sclerosis | Q39798740 | ||
| Myocardial involvement in systemic sclerosis. | Q39847659 | ||
| Cardiac magnetic resonance imaging with pharmacological stress perfusion and delayed enhancement in asymptomatic patients with systemic sclerosis | Q39864090 | ||
| Blunted coronary flow reserve in systemic sclerosis: a sign of cardiac involvement in asymptomatic patients. | Q42712738 | ||
| Absence of epicardial coronary stenosis in patients with systemic sclerosis with severe impairment of coronary flow reserve. | Q42956318 | ||
| Myocardial lesions of progressive systemic sclerosis. A cause of cardiac dysfunction | Q44007356 | ||
| The role of infections in the immunopathogensis of systemic sclerosis--evidence from serological studies | Q44015237 | ||
| Carotid and femoral arterial wall mechanics in scleroderma. | Q44460286 | ||
| Blunted coronary flow reserve in systemic sclerosis | Q44735925 | ||
| A pilot study of subclinical coronary atherosclerosis in systemic sclerosis: coronary artery calcification in cases and controls | Q44768065 | ||
| Lipoprotein profile in limited systemic sclerosis. | Q45256816 | ||
| The impact of systemic sclerosis on arterial wall stiffness parameters and endothelial function | Q46463194 | ||
| Cardiovascular risk and prostanoids in systemic sclerosis | Q46531072 | ||
| Lipoprotein[a] and the lipid profile in patients with systemic sclerosis | Q46659733 | ||
| Influence of low-density lipoprotein (LDL) receptor on lipid composition, inflammation and parasitism during Toxoplasma gondii infection. | Q46721348 | ||
| Antitreponemal antibodies leading to autoantibody production and protection from atherosclerosis in Kitavans from Papua New Guinea | Q46761931 | ||
| Ankle brachial pressure index in systemic sclerosis: influence of disease subtype and anticentromere antibody | Q47574106 | ||
| Antibodies against oxidized low-density lipoproteins in systemic sclerosis | Q47579190 | ||
| Increased serum levels of heat shock protein 70 are associated with low risk of coronary artery disease | Q47934879 | ||
| Blood coagulation, fibrinolysis, and markers of endothelial dysfunction in systemic sclerosis. | Q47967636 | ||
| Short-term estrogen administration improves abnormal endothelial function in women with systemic sclerosis and Raynaud's phenomenon. | Q50857888 | ||
| Coronary angiographic findings in asymptomatic systemic sclerosis. | Q51821801 | ||
| The D allele of angiotensin I-converting enzyme gene insertion/deletion polymorphism is associated with the severity of atherosclerosis. | Q54523446 | ||
| Assessment of vascular function in systemic sclerosis: Indications of the development of nitrate tolerance as a result of enhanced endothelial nitric oxide production | Q57819638 | ||
| Circulating levels of N -(carboxymethyl)lysine are increased in systemic sclerosis | Q63433987 | ||
| Angina pectoris, myocardial infarction and sudden cardiac death with normal coronary arteries: A clinicopathologic study of 9 patients with progressive systemic sclerosis | Q67314586 | ||
| Nifedipine and thallium-201 myocardial perfusion in progressive systemic sclerosis | Q68797448 | ||
| Impotence in scleroderma | Q69505205 | ||
| Limited scleroderma is associated with increased prevalence of macrovascular disease | Q72317541 | ||
| Levels of antibodies against C1q and 60 kDa family of heat shock proteins in the sera of patients with various autoimmune diseases | Q73342830 | ||
| Diastolic dysfunction in patients with systemic sclerosis detected by gated myocardial perfusion SPECT: an early sign of cardiac involvement | Q73535319 | ||
| Anti-endothelial cell antibodies in patients with coronary atherosclerosis | Q74238379 | ||
| Left ventricular diastolic function in systemic sclerosis | Q74254567 | ||
| AECA and ANCA in patients with premature atherosclerosis | Q74630315 | ||
| Effect of long-term estrogen therapy on brachial arterial endothelium-dependent vasodilation in women with Raynaud's phenomenon secondary to systemic sclerosis | Q77750598 | ||
| Myocardial and vascular dysfunction in systemic sclerosis: the potential role of noninvasive assessment in asymptomatic patients | Q79420671 | ||
| Endothelial dysfunction precedes atherosclerosis in systemic sclerosis--relevance for prevention of vascular complications | Q79631405 | ||
| Angiotensin-converting enzyme I/D polymorphism and macrovascular disease in systemic sclerosis | Q79691193 | ||
| The impact of depression, microvasculopathy, and fibrosis on development of erectile dysfunction in men with systemic sclerosis | Q79759454 | ||
| The fine-tuning of anti-oxidized low-density lipoprotein antibodies in cardiovascular disease and thrombosis | Q80158285 | ||
| The heart in scleroderma | Q80842711 | ||
| OxLDL/beta2GPI complexes and autoantibodies in patients with systemic lupus erythematosus, systemic sclerosis, and antiphospholipid syndrome: pathogenic implications for vascular involvement | Q81125970 | ||
| Increased arterial stiffness as the marker of vascular involvement in systemic sclerosis | Q81290300 | ||
| Early atherosclerosis and autoantibodies to heat-shock proteins and oxidized LDL in systemic sclerosis | Q81349086 | ||
| Flow-mediated vasodilation and carotid intima-media thickness in systemic sclerosis | Q81349091 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | atherosclerosis | Q12252367 |
| P304 | page(s) | 259-266 | |
| P577 | publication date | 2010-09-21 | |
| P1433 | published in | Autoimmunity Reviews | Q15754966 |
| P1476 | title | Atherosclerosis and macrovascular involvement in systemic sclerosis: myth or reality | |
| Atherosclerosis and macrovascular involvement in systemic sclerosis: Myth or reality | |||
| P478 | volume | 10 |
| Q30249024 | A critical view on cardiovascular risk in systemic sclerosis. |
| Q38840236 | Adipose-Derived Mesenchymal Stem Cells in Autoimmune Disorders: State of the Art and Perspectives for Systemic Sclerosis. |
| Q38904539 | Advanced Imaging and Diagnostic Methods in the Assessment of Suspected Ischemic Heart Disease in Women |
| Q37668990 | Atherosclerosis in Systemic Sclerosis: a Modern Controversy |
| Q35082399 | Atherosclerosis in systemic sclerosis: a systematic review and meta-analysis |
| Q37690605 | Atherosclerotic plaques occur in absence of intima-media thickening in both systemic sclerosis and systemic lupus erythematosus: a duplexsonography study of carotid and femoral arteries and follow-up for cardiovascular events |
| Q38021696 | Autoimmunity in 2011. |
| Q95824257 | Biological therapy safety in chronic inflammatory arthropathy patients |
| Q34251904 | Cardiac manifestations in systemic sclerosis |
| Q34947193 | Cardiovascular disease in systemic sclerosis |
| Q34081242 | Cardiovascular involvement in autoimmune diseases |
| Q33572573 | Clinical Phenotype of Endothelial Dysfunction in Romanian Scleroderma Patients |
| Q33572381 | Clinical Phenotype of Endothelial Dysfunction in a Lot of Romanian Scleroderma Patients |
| Q38133017 | Clinical aspects of autoimmune rheumatic diseases |
| Q38937968 | Early morphologic and functional changes of atherosclerosis in systemic sclerosis-a systematic review and meta-analysis |
| Q35123740 | Is atherosclerosis an autoimmune disease? |
| Q37690928 | Ischemic arterial events and atherosclerosis in patients with systemic sclerosis: a population-based case-control study |
| Q40201236 | No association of atherosclerosis with digital ulcers in Japanese patients with systemic sclerosis: evaluation of carotid intima-media thickness and plaque characteristics |
| Q33704086 | Prevalence of subclinical atherosclerosis is increased in systemic sclerosis and is associated with serum proteins: a cross-sectional, controlled study of carotid ultrasound |
| Q41079067 | Propylthiouracil modulates aortic vasculopathy in the oxidative stress model of systemic sclerosis. |
| Q38446736 | Relationship between body composition and both cardiovascular risk factors and lung function in systemic sclerosis |
| Q44715187 | Reply: To PMID 22899452. |
| Q38214567 | Risk of coronary artery disease in patients with systemic sclerosis: a systematic review and meta-analysis. |
| Q34979110 | Rosuvastatin improves impaired endothelial function, lowers high sensitivity CRP, complement and immuncomplex production in patients with systemic sclerosis--a prospective case-series study |
| Q64111768 | Study of MRI brain findings and carotid US features in systemic sclerosis patients, relationship with disease parameters |
| Q37826112 | The diagnostic and clinical significance of anti-muscarinic receptor autoantibodies |
Search more.